Literature DB >> 3739882

Reduced coronary flow and resistance reserve in primary scleroderma myocardial disease.

A Nitenberg, J M Foult, A Kahan, J Perennec, J Y Devaux, C J Menkes, B Amor.   

Abstract

The maximum coronary vasodilator capacity after intravenous dipyridamole (0.14 mg X kg-1 X min-1 X 4 minutes) was studied in seven patients with primary scleroderma myocardial disease and compared to that of seven control subjects. Hemodynamic data and left ventricular angiographic data were not different in the two groups. The coronary flow reserve was evaluated by the dipyridamole/basal coronary sinus blood flow ratio (D/B CSBF) and the coronary resistance reserve by the dipyridamole/basal coronary resistance ratio (D/B CR). Coronary reserve was greatly impaired in the group with primary scleroderma myocardial disease: D/B CSBF was lower than in the control group (2.54 +/- 1.37 vs 4.01 +/- 0.56, respectively; p less than 0.05) and D/B CR was higher than in the control group (0.47 +/- 0.25 vs 0.23 +/- 0.04, respectively; p less than 0.05). Such a decreased coronary flow and resistance reserve in patients with primary scleroderma myocardial disease was not explained by an alteration of left ventricular function. It may be an important contributing factor in the pathogenesis of primary scleroderma myocardial disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3739882     DOI: 10.1016/0002-8703(86)90267-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension.

Authors:  Jens Vogel-Claussen; Jan Skrok; Monda L Shehata; Sukhminder Singh; Christopher T Sibley; Danielle M Boyce; Noah Lechtzin; Reda E Girgis; Steven C Mathai; Thomas A Goldstein; Jie Zheng; João A C Lima; David A Bluemke; Paul M Hassoun
Journal:  Radiology       Date:  2010-10-22       Impact factor: 11.105

2.  Electrocardiographic evaluation in patients with systemic scleroderma and without clinically evident heart disease.

Authors:  Anna Biełous-Wilk; Małgorzata Poreba; Edyta Staniszewska-Marszałek; Rafał Poreba; Maciej Podgórski; Dariusz Kałka; Dariusz Jagielski; Lesław Rusiecki; Witold Pilecki; Eugeniusz Baran; Ryszard Andrzejak; Małgorzata Sobieszczańska
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

Review 3.  The right ventricle in scleroderma (2013 Grover Conference Series).

Authors:  Paul M Hassoun
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 4.  Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging.

Authors:  Attila Feher; Albert J Sinusas
Journal:  Circ Cardiovasc Imaging       Date:  2017-08       Impact factor: 7.792

5.  Coronary angiographic findings in asymptomatic systemic sclerosis.

Authors:  El-Gohary Tarek; Amin E Yasser; Tamer Gheita
Journal:  Clin Rheumatol       Date:  2006-01-27       Impact factor: 2.980

6.  Myocardial 201Tl washout after combined dipyridamole submaximal exercise stress: reference values from different patient groups.

Authors:  L Fridrich
Journal:  Eur J Nucl Med       Date:  1989

7.  Left ventricular ischemia in pre-capillary pulmonary hypertension: a cardiovascular magnetic resonance study.

Authors:  Karthigesh Sree Raman; Ranjit Shah; Michael Stokes; Angela Walls; Richard J Woodman; Rajiv Ananthakrishna; Jennifer G Walker; Susanna Proudman; Peter M Steele; Carmine G De Pasquale; David S Celermajer; Joseph B Selvanayagam
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

8.  Identification of myocardial damage in systemic sclerosis: a nuclear cardiology approach.

Authors:  Kenichi Nakajima; Shinro Matsuo; Minoru Hasegawa; Seigo Kinuya; Kazuhiko Takehara
Journal:  Int J Rheumatol       Date:  2010-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.